Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMedOpen access

Comparisons of miRNA profiles of exosomes derived from human iPSCs, ADSCs, and BMSCs and effects on chondrocyte function.

Chang LH., Chuang SC., Wu SC., Fu YC., Chen JW., Wu CW.

Laboratory Study on Hip, published in Bone Joint Res (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Bone Joint Res (2025)
Country
England
Reported sample size
—
Source database
PubMed
PMID
40823751
PMCID
PMC12359900
DOI
10.1302/2046-3758.148.BJR-2024-0267.R4
Citations
3

Abstract (original English)

Aims This study aimed to identify and compare the microRNA (miRNA) profiles of exosomes derived from human induced pluripotent stem cells (iPSCs), bone marrow mesenchymal stem cells (BMSCs), and adipose tissue-derived stem cells (ADSCs) (hiPSC-Exos, hBMSC-Exos, and hADSC-Exos), and their functional effects on human articular chondrocytes (hACs). Methods hiPSC-Exos, hBMSC-Exos, and hADSC-Exos were collected from the appropriate cells cultured in 10% bovine exosome-depleted fetal bovine serum (de-Exo-FBS) for 48 hours. Next-generation sequencing (NGS) and bioinformatics were used to analyze the small RNA profiles of these exosomes. The biological functions of hACs were examined after a 12-day treatment with exosomes. Results hBMSC-Exos and hADSC-Exos had similar miRNA profiles but were largely different from hiPS-Exos. There were 17 highly expressed miRNAs in hiPSC-Exos, 13 miRNAs in hADSC-Exos, and 11 miRNAs in hBMSC-Exos. Among them, seven miRNAs overlapped between the hBMSC-Exos and hADSC-Exos, and only three of them (hsa-miR-16-5p, hsa-miR-25-3p, and hsa-miR-93-5p) overlapped among all three exosomes. The putative target genes of the three overlapping exosomal miRNAs, and high-scoring target genes, including MAN2A1, ZNFX1, PHF19, GPR137C, ENPP5, B3GALT2, FNIP1, PKD2, and FBXW7, were identified. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment a

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research